Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

East Timor dengue fatality down, DHF (dengue haemorrhagic fever) rates still high:

This article was originally published in Clinica

Executive Summary

More than 70% of the 178 hospitalised cases of dengue infection in East Timor had clinical features compatible with dengue haemorrhagic fever (DHF), the World Health Organization reported on February 10. The remainder were diagnosed as suspected dengue fever - ie the less virulent form of the disease - using WHO standard case definitions. The case fatality ratio has decreased since the beginning of the outbreak, but last stood at 9%, at 16 deaths.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel